首页 我的

转载 炎症与难治性抑郁

朱健民 副主任医师 江西省精神病院 精神科
2013-10-20 300人已读
朱健民 副主任医师
江西省精神病院

An increase of inflammatory markers has also been seen in patients with anxiety and personality disorders. Bipolar disorder has been associated with increased blood inflammatory markers as well as increased inflammatory cytokines, NF-κB, and markers of microglial activation in postmortem brain tissue. Patients with medical illnesses are well known to exhibit increased inflammation secondary to infection and the tissue damage and destruction that can activate the inflammatory response. The data indicate that treatment resistance may be in part a function of activation of inflammatory pathways. The clinical factors that may alert the clinician to which patients are most likely to exhibit increased inflammatory biomarkers and risk for treatment resistance include obesity, childhood maltreatment, bipolar disorder, and comorbid medical illness

江西省精神病医院精神科朱健民

Multiple lifestyle, environmental, psychiatric, and medical factors contribute to and are a function of an inflammatory milieu associated with increased inflammatory cytokines, which can reduce the availability of monoamines, inhibit neurogenesis, and increase glutamate. Conventional antidepressants act on monoamine pathways to increase monoamine availability and require neurogenesis for efficacy. Moreover, glutamate is not a primary target of conventional antidepressant therapy. Cytokine effects on these biological processes thus conspire to sabotage and circumvent the mechanism of action of conventional antidepressants, leading to treatment resistance.

本文为转载文章,如有侵权请联系作者删除。

有帮助
期待更新

朱健民 副主任医师

江西省精神病院 精神科

问医生 去挂号

更多文章

炎症与难治性抑郁 的相关咨询
由于相关规范,IOS用户暂不可在小程序订阅